Ramzi Shawahna, PhD


Pharmaceutical Care Services for Patients With Diabetes: A Systematic Scoping Review

Major databases were systematically searched for articles reporting on pharmaceutical care services for patients with diabetes, and 86 pharmaceutical care services were qualitatively synthesized.

Wayne Winegarden, PhD
Wayne Winegarden, PhD


Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome

Wayne Winegarden, PhD, of the Pacific Research Institute, explains the harm that white bagging policies cause health systems and how replacing them with new measures to boost market competition could help patients.

Emily Durden, PhD


Characterizing Obesity in a Large Health Care Delivery System.

The prevalence of obesity in the Sutter Health system between 2015 and 2020 was 35%. Differences by race/ethnicity, health insurance, smoking status, and comorbidities were examined.

Andrew Mulcahy, PhD, MPP


Projected US Savings From Biosimilars, 2021-2025

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.

Evelyn P. Davila, PhD, MPH


Racial/Ethnic Differences in Autoimmune Disease Prevalence in US Claims/EHR Data

This analysis uses claims and electronic health records from 2021 to examine racial and ethnic variations in immune-mediated inflammatory diseases in the United States.

Laina McInerney


A Multistakeholder Effort in Pennsylvania to Improve the Accuracy of Reporting Fatal Drug Overdoses

The authors describe a novel training program for death certifiers in Pennsylvania, which has been designed to specifically focus on some of the main challenges in the death certification process and resulted in a useful model that can potentially be adopted by other states or municipalities.

Brand Newland, PharmD, MBA


Policy Changes Are Needed to Further Reduce Perioperative Opioid Use

Efforts to close existing policy gaps and misaligned payment practices in current opioid management practices can promote greater utilization of multimodal opioid-sparing pain management options.

Sameer V. Awsare, MD


Opioid Safety Initiative Associated With Decreased Emergency Department Opioid Prescribing

A scalable health system–wide emergency physician education and feedback initiative was associated with decreased opioid prescribing, in excess of background temporal decline.

Frannie R. Kronenberg, MD, MSc


The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).

Rubén Francisco Flores, PhD


Process Reengineering and Patient-Centered Approach Strengthen Efficiency in Specialized Care

Improving efficiency is complex and requires a multimodal approach. Health information systems, patient feedback, and multidisciplinary teams are components that can improve clinical processes.

Deanna Ferreri, PhD


Despite Concerns Over Extrapolation, Bevacizumab Biosimilars Are Widely Used in mCRC

A review article investigating the use of bevacizumab biosimilars found that despite lingering concerns about their usage for extrapolated indications, bevacizumab biosimilars are regularly used in metastatic colorectal cancer (mCRC) even though clinical tests only evaluate them in patients with lung cancer.

Patricia Hayes, MD


Contributor: Improving Seniors’ Health and Outcomes With a Value-Based Care Team Approach

A value-based care team approach can be utilized to adequately treat patients’ medical problems, particularly by addressing the social, economic, and environmental challenges they’re facing in their everyday lives.

Cara McDonnell, MPH


Financial Factors That Influenced Telemedicine Delivery During the COVID-19 Pandemic

This study describes financial issues that influenced telemedicine provision and use for patients with chronic conditions and their providers during COVID-19.

Robert Pittman, SVP, Gvernment Affairs, Modivcare
Robert Pittman


Contributor: Technology, Supplemental Services in MA Can Help Improve Participant Health

Social determinants of health present many health-related challenges for Medicare Advantage (MA) plan members, something these plans are looking to overcome by diversifying their service offerings.

Jay Anders, MD


Contributor: Giving Clinicians Top-line Data to Help Manage Chronic Conditions

To accurately understand the progression or control of a condition, physicians require ready access to key indicators relevant to that illness. The industry should do a better job of making them available.

Weihao Zhou, MS


Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.

Pei Ting Tan, MSc


Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation Unit

This study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.

Jeremy Rubel


Contributor: Using Technology to Streamline Enrollment Into Available Medicare Subsidy Programs

Medicare Advantage plans can drive significant, sustainable, and scalable improvements to health outcomes; reduce cost; and boost retention and top-line revenue by enrolling beneficiaries into the comprehensive set of state and federal low-income programs available to them.

Stephen G. Salzbrenner, MD


Influence of Prior Authorization Requirements on Provider Clinical Decision-Making

An online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.

Yolaine Jeune-Smith, PhD


Oncologists’ Perceptions and Utilization of US Therapeutic Oncology Biosimilars

Biosimilar use in clinical practice is determined by oncologists’ perceptions of and willingness to prescribe them. The authors investigated US oncologists’ perceptions and use of biosimilars.

Sean M. Reed, PhD, APRN


Modeling of an Alternative Reimbursement Method for Palliative Care

The authors modeled a version of the Patient and Caregiver Support for Serious Illness alternative reimbursement structure for palliative care using data from the Statin Trial.

Heidy Medina, MPH


Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.

Benjamin Ukert, PhD


On the Impact of Predictive Analytics–Driven Disease Management Interventions

Predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.

Loida Tamayo, PhD


Sex Differences in Medicare Beneficiaries’ Experiences by Low-Income Status

Only low-income male Medicare beneficiaries had worse patient experience than their female counterparts. The authors discuss opportunities to improve experiences for all patients.

Yi Li, PhD


Effective Prevention and Management of COVID-19 in Outpatient Hemodialysis Patients

The authors introduce a mobile phone app that may effectively prevent and manage coronavirus disease 2019 (COVID-19) in outpatient hemodialysis patients in Sichuan Province, China.

Peter F. Cronholm, MD, MSCE


Patient Perspectives on Technology-Based Approaches to Social Needs Screening

Patients are essential stakeholders in designing systems to capture social needs. The authors present key findings from patient interviews regarding social needs screening through technology-based modalities.

Stephen J. Bartels, MD, MS


The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).

CH LogoCenter for Biosimilars Logo